Ellagic acid inhibits HIV-1 infection in vitro: Potential role as a novel microbicide.

A PromsongT ChuenchitraK SaipinS TewtrakulP PanichayupakaranantS SatthakarnWipawee Nittayananta

Published in: Oral diseases (2018)

We conclude that ellagic acid can inhibit HIV-1 infection without cytotoxicity. Thus, it may be a new effective agent that has potential to be developed as a novel microbicide against HIV-1.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv aids
hiv testing
hepatitis c virus
men who have sex with men
human health
risk assessment